This site is intended for health professionals only
Newsletter
Hospital Healthcare Europe
Login
Twitter
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
Home
>
Dermatology
Dermatology
Celgene’s Otezla® (apremilast) receives European marketing authorisation
A global call for awareness of psoriasis as a disability
Celgene receives positive CHMP opinion for OTEZLA® (apremilast)
International study shows improved outcomes for psoriasis patients
Building a better world for people with psoriasis
New findings from PSOLAR show persistency difference among biologic therapies
Sanofi and Regeneron announce positive phase 2 Dupilumab results
Management of facial flushing in rosacea
Drugs duo announce dupilumab in atopic dermatitis results
Building a better world for people with psoriasis
Global Psoriasis Atlas to be mapped out
Developments in treating actinic keratosis
« Previous
1
…
9
10
11
12
13
…
21
Next »
Most read
1
Oral vitamin A could become an alternative to isotretinoin for acne
by Rod Tucker
2
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
by Rod Tucker
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
by Rod Tucker
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
by Rod Tucker
5
Launch of the new Hospital Pharmacy Europe Mobile App
by aporter2
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: